Spotlight
Money Desk
Obituaries
Classifieds
Families First
News
Weather
Specialists
Sports
Business
Opinion
Consumer
Health
Life
Out & About
Login
Weather
22 NC counties are under alert.
Just In
Flash flood warnings: National Weather Service issues a flash flood warning for Vance, Granville and Person counties until 2:15 a.m. Thursday
Just In
Flood advisories: Person, Granville, Vance, Warren, Halifax, Franklin, Nash & parts of Durham & Orange counties under advisory until 1:30 a.m.
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
Gold
Crude Oil
Local Stocks
WRALTechWire 30
WRALTechWire 30
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Galapagos NV ADR
(NQ:
GLPG
)
27.00
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EDT, Jul 17, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
0
Open
27.00
Bid (Size)
26.79 (5)
Ask (Size)
26.88 (2)
Prev. Close
27.00
Today's Range
27.00 - 27.00
52wk Range
24.78 - 44.25
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
GLPG Stock Earnings: Galapagos Beats EPS, Misses Revenue for Q1 2024
June 25, 2024
GLPG stock results show that Galapagos beat analyst estimates for earnings per share but missed on revenue for the first quarter of 2024.
Via
InvestorPlace
Adaptimmune and Galapagos Sign Clinical Collaboration Agreement with an Option to Exclusively License Adaptimmune's TCR T-cell Therapy Candidate, uza-cel, in Head & Neck Cancer and Potential Future Solid Tumor Indications
May 30, 2024
Adaptimmune and Galapagos to conduct clinical proof-of-concept trial to evaluate the safety and efficacy of uza-cel (next-generation MAGE-A4 TCR T-cell...
Via
Newsfile
Performance
YTD
-34.69%
-34.69%
1 Month
+4.90%
+4.90%
3 Month
-7.60%
-7.60%
6 Month
-30.23%
-30.23%
1 Year
-36.49%
-36.49%
More News
Read More
Galapagos Downgraded, Pharma Firm Faces Uphill Battle With Slow Pipeline Progress: Analyst
April 01, 2024
Via
Benzinga
Frontier Medicines Announces Oversubscribed $80 Million Series C Financing to Support Progress of Clinical-Stage Pipeline
February 22, 2024
From
Frontier Medicines
Via
GlobeNewswire
8 Analysts Have This to Say About Galapagos
July 17, 2023
Via
Benzinga
Where Galapagos Stands With Analysts
June 12, 2023
Via
Benzinga
JP Morgan Maintains Neutral Rating for Galapagos: Here's What You Need To Know
May 31, 2023
Via
Benzinga
Earnings Outlook For Galapagos
May 03, 2023
Via
Benzinga
European Drugmaker Galapagos Collaborates With Biotech BridGene Biosciences To Develop Cancer Treatments
January 03, 2024
Via
Benzinga
GLPG Stock Earnings: Galapagos Beats EPS, Beats Revenue for Q3 2023
December 13, 2023
Via
InvestorPlace
Benzinga's Top Ratings Upgrades, Downgrades For May 8, 2023
May 08, 2023
Via
Benzinga
BigCommerce, ContextLogic And Other Big Stocks Moving Lower In Friday's Pre-Market Session
February 24, 2023
Via
Benzinga
Earnings Preview For Galapagos
February 23, 2023
Via
Benzinga
Where Galapagos Stands With Analysts
November 07, 2022
Via
Benzinga
Galapagos' Blood Cancer Candidate Shows 100% Objective Response Rate In Relapsed/Refractory Patients
February 10, 2023
Via
Benzinga
Why Galapagos Stock Is Falling Today
February 09, 2023
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For January 23, 2023
January 23, 2023
Via
Benzinga
Where Galapagos Stands With Analysts
September 09, 2022
Via
Benzinga
Twitter Rolls Out 'Blue For Business,' Visa Pitches Auto-Payments On Ethereum Blockchain, Justin Bieber Slams H&M: Today's Top Stories
December 20, 2022
Via
Benzinga
On A Mission As Top European Player, Galapagos Looks For Acquisition Targets
December 20, 2022
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For November 7, 2022
November 07, 2022
Via
Benzinga
After FDA, European Agency Limits Use Of Certain JAK Inhibitors Amid Safety Concerns
October 31, 2022
Via
Benzinga
Expert Ratings for Galapagos
October 13, 2022
Via
Benzinga
3 Biotech Stocks to Sell in October
September 29, 2022
Via
InvestorPlace
Benzinga's Top Ratings Upgrades, Downgrades For September 9, 2022
September 09, 2022
Via
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.